Rocket Pharmaceuticals: Q4 Earnings Snapshot

SelfRugger · 2026-04-09T11:39:05+00:00

Rocket Pharmaceuticals reported a fourth-quarter loss of $42.5 million, or 38 cents per share, surpassing Wall Street's expectations of a 42 cents loss. For the year, total losses reached $223.1 million, or $2.01 per share.

SelfRugger

2026-04-09 11:39:05

Abstract generation in progress

Rocket Pharmaceuticals: Q4 Earnings Snapshot

Associated Press Finance

Fri, February 27, 2026 at 6:04 AM GMT+9 1 min read

In this article:

RCKT

+4.62%

CRANBURY, N.J. (AP) — CRANBURY, N.J. (AP) — Rocket Pharmaceuticals Inc. (RCKT) on Thursday reported a loss of $42.5 million in its fourth quarter.

On a per-share basis, the Cranbury, New Jersey-based company said it had a loss of 38 cents.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 42 cents per share.

For the year, the company reported a loss of $223.1 million, or $2.01 per share.

This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on RCKT at

Terms and Privacy Policy

Privacy Dashboard

More Info

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.